Healing Reimagined
Immunicom’s Immunopheresis® is designed to empower
patients to best live their lives while receiving revolutionary
cancer treatment.This unique immunotherapy is intended
to meaningfully improve patients’ quality of life and
avoid typical side-effects.
LATEST MILESTONE
Immunicom Announces Addition of Key Industry Leaders to Board of Directors
A transformative immunotherapy
Immunicom creates novel immunotherapies designed to treat a variety of diseases using Immunicom’s breakthrough Immunopheresis® technology platform.
The breakthrough Immunopheresis approach uses a therapeutic device that works outside of the body and is designed to treat cancer, inflammatory, renal, and autoimmune diseases by removing barriers from the blood that block the immune system from doing its job.
Our Recognition
Designed to treat
multiple diseases
multiple diseases
Worldwide clinical trials are underway at leading hospitals to evaluate Immunopheresis in several cancer types, both as a singular therapy and in combination with other treatments.
Latest News
April 28, 2022
Immunicom Presents New Data at AACR 2022 of LW-02 Cartridge Immunopheresis® Therapy from Ongoing mTNBC Clinical Trial in Chemo-Refractory Patients
April 18, 2022
AACR Annual Meeting 2022
April 12, 2022
Immunicom Announces Addition of Key Industry Leaders to Board of Directors
March 3, 2022
Immunicom Announces Dr. Julie Tubbs and Marilyn Panahi to Join Senior Leadership Team
Our Mission
To improve the quality of life for patients
in a meaningful way and expedite their
path to a healthy future.
Get in touch today
Let’s talk about what we can achieve together
Learn more about
our team
our team